Drug History: RAZADYNE ER

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	RAZADYNE ER
FDA Application No:	(NDA) 021615
Active Ingredient(s):	GALANTAMINE HYDROBROMIDE
Company:	JANSSEN

Label History

View the label approved on December 29, 2004 for RAZADYNE ER, (NDA) 021615

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
4/27/2006	005	Labeling Revision	Letter
4/27/2006	004	Labeling Revision	Letter
4/27/2006	003	Labeling Revision	Letter
5/2/2005	002	Labeling Revision	Letter
4/27/2006	001	Labeling Revision	Letter
12/22/2004	000	Approval	Letter Label Review Other Important Information from FDA

There are no Therapeutic Equivalents